Early Sign, Stay Fine

Transforming cerebrovascular diagnosis with AI —
from detection to workflow integration

RDX-Aneurysm

AI-powered MRA detection for accurate, early aneurysm diagnosis

95% overall ave. sensitivity
including aneurysm < 3mm

90% sensitivity
for aneurysm < 3mm

Automatic 3D Vessel Segmentation

For clear visualization and planning

For Radiologists

AI detects subtle aneurysms on MRA scans, reducing missed diagnoses and easing cognitive burden in clinical practice.

For Hospitals & Partners

Seamlessly integrates with PACS, enabling earlier treatment decisions for hospitals and creating incremental revenue opportunities for device partners.

Grid
Grid

BENEFITS

Why RADAX.AI?

AI-powered precision for earlier detection, smarter workflow, and better outcomes

Higher Sensitivity

AI detects subtle aneurysms (<3mm), reducing missed diagnoses and supporting confident reporting.

Higher Sensitivity

AI detects subtle aneurysms (<3mm), reducing missed diagnoses and supporting confident reporting.

Workflow Integration

Seamlessly integrates with PACS/HIS systems, ensuring zero disruption to radiologists’ routine.

Workflow Integration

Seamlessly integrates with PACS/HIS systems, ensuring zero disruption to radiologists’ routine.

Clinical Efficiency

Supports faster case triage, saving time for radiologists and improving patient outcomes consequently.

Clinical Efficiency

Supports faster case triage, saving time for radiologists and improving patient outcomes consequently.

Multi-Center Validation

Validated across multiple hospitals and scanner vendors, ensuring generalizability in real-world settings.

Multi-Center Validation

Validated across multiple hospitals and scanner vendors, ensuring generalizability in real-world settings.

Trusted Support

Expert team of radiologists and AI scientists providing continuous updates and clinical collaboration.

Trusted Support

Expert team of radiologists and AI scientists providing continuous updates and clinical collaboration.

Revenue Impact

Unlocks incremental device utilization and new growth opportunities for medical technology partners.

Revenue Impact

Unlocks incremental device utilization and new growth opportunities for medical technology partners.

  • Multi-Center Validation

  • Missed Symptoms

  • Seamless Integration

  • Improved Sensitivity

  • Enhanced Accuracy

  • Workflow Efficiency

  • Clinical Trial Ready

  • Scalable SaaS

  • Vendor-Agnostic

  • Seeking Strategic Partners

FOUNDERS NOTE

“As an interventional radiologist, I’ve seen how easily subtle aneurysms are missed. RADAX.AI exists to change that detecting rapidly, diagnosing rationally, and transforming outcomes radically.„

“As an interventional radiologist, I’ve seen how easily subtle aneurysms are missed.

RADAX.AI exists to change that detecting rapidly, diagnosing rationally, and transforming outcomes radically.„

user pic

Co-founder

COMPARISON

Why RADAX.AI Stands Out

Proven in medical centers, validated in clinics, and trusted by experts worldwide.

Detect Subtle Lesions Early

Integrated into Clinical Workflow

Contrast-free MRA Images

Prevent Severe Complications

Scalable, Future-Proof Platform

Detect Subtle Lesions Early

Integrated into Clinical Workflow

Contrast-free MRA Images

Prevent Severe Complications

Scalable, Future-Proof Platform

Others

Limited Detection

Separate Viewers or Manual Data Transfer

Contrast-needed CTA Images

Reactive Use in Acute Events

Fragmented, One-Off Solutions

Limited Detection

Separate Viewers or Manual Data Transfer

Contrast-needed CTA Images

Reactive Use in Acute Events

Fragmented, One-Off Solutions